Application Nr Approved Date Route Status External Links
ANDA213532 None Intravascular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Levetiracetam In Sodium Chloride Injection Is Indicated For Adjunct Therapy In Adults (≥16 Years Of Age) With The Following Seizure Types When Oral Administration Is Temporarily Not Feasible: Partial Onset Seizures ( 1.1 ) Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy ( 1.2 ) Primary Generalized Tonic-Clonic Seizures ( 1.3 ) 1.1 Partial Onset Seizures Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Partial-Onset Seizures In Adults With Epilepsy. 1.2 Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Myoclonic Seizures In Adults With Juvenile Myoclonic Epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Primary Generalized Tonic-Clonic Seizures In Adults With Idiopathic Generalized Epilepsy. 1.4 Limitations Of Use Levetiracetam In Sodium Chloride Injection Is An Antiepileptic Drug Indicated For Adult Patients (16 Years And Older) When Oral Administration Is Temporarily Not Feasible.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments